Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ginkgo Bioworks Holdings Inc shares valued at $831 were purchased by Che Austin on Nov 07 ’24. At $8.39 per share, Che Austin acquired 99 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Coen Steven P. sold 333 shares, netting a total of over 2,523 in proceeds. Following the sale of shares at $7.58 each, the insider now holds 6,456 shares.
Before that, Dmytruk Mark E. had sold 1,322 shares from its account. In a trade valued at $10,015, the insider traded Ginkgo Bioworks Holdings Inc shares for $7.58 each. Upon closing the transaction, the insider’s holdings decreased to 1,322 shares, worth approximately $0.26 million.
As published in a research note from BTIG Research on May 15, 2024, Ginkgo Bioworks Holdings Inc [DNA] has been rated down from a Neutral to a Sell. Analysts at William Blair downgraded the stock from ‘”a Mkt perform”‘ to ‘”an Underperform”‘ outlook in a report released in early May. As of November 14, 2023, Raymond James has decreased its “an Outperform” rating to a “Mkt perform” for DNA. Earlier on November 09, 2023, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for DNA stock which previously was a “a Buy”.
Analyzing DNA Stock Performance
During the last five days, there has been a surge of approximately 9.97%. Over the course of the year, Ginkgo Bioworks Holdings Inc shares have dropped approximately -87.60%. Shares of the company reached a 52-week high of $68.80 on 01/02/24 and a 52-week low of $5.26 on 09/10/24. A 50-day SMA is recorded $7.58, while a 200-day SMA reached $25.14. Nevertheless, trading volume fell to 0.59 million shares from 0.84 million shares the previous day.
Support And Resistance Levels for Ginkgo Bioworks Holdings Inc (DNA)
According to the 24-hour chart, there is a support level at 8.18, which, if violated, would cause prices to drop to 7.97. In the upper region, resistance lies at 8.55. The next price resistance is at 8.71. RSI (Relative Strength Index) is 53.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.01, which suggests the price will decrease in the coming days. Percent R is at 59.05%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
